ATLASHarmony Biosciences (HRMY) earnings date: Nov 4, 2026
Harmony Biosciences (HRMY) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, before the open. Analysts expect EPS of $1.00.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on HRMY
| Last price | $38.76 (+0.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.3% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Harmony Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Harmony Biosciences reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Harmony Biosciences. You can switch it off at any time.
Alert me before HRMY reportsFree to start. Creating an account takes under a minute.
HRMY earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $1.00 |
| Last report | Aug 4, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -6.9% |
| Average move around a report | ±5.7% (last 5) |
| Sector | Healthcare · Biotechnology |
Harmony Biosciences earnings history: last 5 reports
Harmony Biosciences last reported on Aug 4, 2026: EPS of $1.50 against an estimate of $1.15 (+30.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 4, 2026 | $1.15 | $1.50 | +30.4% | Beat | +7.4% |
| Jun 9, 2026 | $0.48 | $0.22 | -54.2% | Miss | +9.5% |
| May 7, 2026 | $0.93 | $0.79 | -15.0% | Miss | -5.5% |
| Apr 14, 2026 | $0.44 | $0.48 | +9.1% | Beat | +0.6% |
| Mar 30, 2026 | -$0.65 | -$0.68 | -4.6% | Miss | +5.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for HRMY
See the fair value, the probability range and the earnings history of Harmony Biosciences on its ATLAS page.
Harmony Biosciences (HRMY) stock analysisPlans from €3.99 a month.
Harmony Biosciences earnings: frequently asked questions
When does Harmony Biosciences (HRMY) report earnings?
Harmony Biosciences is scheduled to report on Wednesday, November 4, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for HRMY?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $1.00 per share (USD). Estimates can change before the report.
How often does HRMY beat earnings estimates?
Of its last 5 reports with a recorded result, Harmony Biosciences beat the EPS estimate 2 times; the average surprise was -6.9%. Past results do not predict the next one.
How much does HRMY move around earnings?
Over its last 5 reports the stock moved an average of 5.7% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Harmony Biosciences beat earnings estimates last quarter?
Harmony Biosciences last reported on Aug 4, 2026: EPS of $1.50 against an estimate of $1.15 (+30.4% surprise), a beat.
How much does HRMY usually move in a day?
On a normal trading day the ATLAS model puts HRMY’s one-day range at about ±2.3%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer